Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Early onset hair loss in young men is common and linked to family history and alcohol use.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

Avoiding smoking, stress, obesity, and poor diet may help reduce hair loss in young Egyptian males.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Classifying curl patterns might help doctors assess and treat hair loss better.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

The study concluded that a new method can effectively assess scalp sun damage in balding men, which increases with age and sun exposure.

Early hair loss in men may signal broader health issues similar to PCOS in women.

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

Women with AGA have higher lipid levels, increasing heart disease risk.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

A new treatment for hair loss shows promise with fewer side effects.

Higher IMA levels in male AGA patients, especially if obese, may link AGA to metabolic and heart issues.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Women with hair loss may have higher heart disease risk.

Early hair loss may indicate risk of insulin resistance.

Smoking increases early hair loss risk in men; quitting may help prevent it.

Balding and low testosterone increase risk of urinary stones.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Hair color is not a risk factor for developing alopecia areata.

Alcohol may slightly increase the risk of hair loss, but the link is uncertain.